Nadjar, Agnès <br/><br/>
Priming for l-dopa-induced dyskinesia in Parkinson's disease: a feature inherent to the treatment or the disease?  [electronic resource] 

 -  Progress in neurobiology  Jan 2009 
 - 1-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>0301-0082 
<br/><br/><label>Standard No.: </label>10.1016/j.pneurobio.2008.09.013  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antiparkinson Agents--adverse effects<br/>Brain--metabolism<br/>Dopamine--deficiency<br/>Dyskinesia, Drug-Induced--etiology<br/>Humans<br/>Levodopa--adverse effects<br/>Parkinson Disease--drug therapy